- Report
- August 2025
- 188 Pages
Global
From €3187EUR$3,545USD£2,766GBP
€3541EUR$3,939USD£3,073GBP
- Report
- August 2025
- 198 Pages
Global
From €3187EUR$3,545USD£2,766GBP
€3541EUR$3,939USD£3,073GBP
- Report
- August 2025
- 185 Pages
Global
From €3187EUR$3,545USD£2,766GBP
€3541EUR$3,939USD£3,073GBP
- Report
- August 2025
- 197 Pages
Global
From €3187EUR$3,545USD£2,766GBP
€3541EUR$3,939USD£3,073GBP
- Report
- August 2025
- 187 Pages
Global
From €3187EUR$3,545USD£2,766GBP
€3541EUR$3,939USD£3,073GBP
- Report
- August 2025
- 183 Pages
Global
From €3187EUR$3,545USD£2,766GBP
€3541EUR$3,939USD£3,073GBP
- Report
- August 2025
- 183 Pages
Global
From €3187EUR$3,545USD£2,766GBP
€3541EUR$3,939USD£3,073GBP
- Report
- August 2025
- 192 Pages
Global
From €3187EUR$3,545USD£2,766GBP
€3541EUR$3,939USD£3,073GBP
- Report
- January 2026
- 181 Pages
Global
From €4045EUR$4,500USD£3,511GBP
- Report
- January 2026
- 180 Pages
Global
From €4045EUR$4,500USD£3,511GBP
- Report
- January 2026
- 182 Pages
Global
From €4045EUR$4,500USD£3,511GBP
- Report
- January 2026
- 180 Pages
Global
From €4045EUR$4,500USD£3,511GBP
- Report
- January 2026
- 185 Pages
Global
From €4045EUR$4,500USD£3,511GBP
- Report
- January 2026
- 180 Pages
Global
From €4045EUR$4,500USD£3,511GBP
- Report
- January 2026
- 185 Pages
Global
From €4045EUR$4,500USD£3,511GBP
- Report
- January 2026
- 182 Pages
Global
From €4045EUR$4,500USD£3,511GBP
- Report
- January 2026
- 181 Pages
Global
From €4045EUR$4,500USD£3,511GBP
- Report
- November 2025
- 185 Pages
Global
From €4045EUR$4,500USD£3,511GBP
- Report
- August 2025
- 188 Pages
Global
From €4045EUR$4,500USD£3,511GBP
- Report
- June 2025
- 182 Pages
Global
From €4045EUR$4,500USD£3,511GBP

The mRNA market within the biotechnology industry is a rapidly growing sector that focuses on the development of messenger ribonucleic acid (mRNA) technology. mRNA is a type of genetic material that is used to create proteins and is a key component of gene therapy. mRNA technology has been used to develop treatments for a variety of diseases, including cancer, heart disease, and neurological disorders. mRNA technology has also been used to develop vaccines for infectious diseases.
The mRNA market is driven by the increasing demand for mRNA-based treatments and vaccines, as well as the growing number of applications for mRNA technology. Companies in the mRNA market are focused on developing mRNA-based treatments and vaccines, as well as developing new applications for mRNA technology. Some of the major companies in the mRNA market include Moderna, BioNTech, CureVac, and Arcturus Therapeutics. Show Less Read more